Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 6Neoplasm Metastasis 5Melanoma 3Cholangiocarcinoma 3Breast Neoplasms 3Sarcoma 2Osteosarcoma 2Liver Neoplasms 2Kidney Neoplasms 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Wilms Tumor 1Urinary Bladder Neoplasms 1Unresectable Solid Tumors 1Solid Tumor, Adult 1Skin Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Retinoblastoma 1Rectal Neoplasms 1Pancreatic Adenocarcinoma Locally Advanced 1Neuroblastoma 1Lung Neoplasms 1Liver Metastasis 1High-Burden Metastatic Solid Tumors 1Hepatoblastoma 1Gastric Cancer Metastatic to Liver 1Diabetes Mellitus, Insulin-Dependent, 12 1Desmoid Tumors 1Colonic Neoplasms 1

Interventions

Electroporation 1Cryosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Pancreatic Adenocarcinoma Locally Advanced × Cryosurgery × Clear all
NCT07306286 2025-12-29

Cryoablation Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy

Ruijin Hospital

Phase 2 Recruiting
20 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma Locally Advanced

Data powered by HemOnc (CC BY 4.0) Colophon âš¡